DAU 6285: A novel antagonist at the putative 5-HT4 receptor
- 31 December 1992
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 51 (8) , 583-592
- https://doi.org/10.1016/0024-3205(92)90227-g
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1992
- Identification of putative 5-HT4 receptors in guinea-pig ascending colonEuropean Journal of Pharmacology, 1991
- Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brainaNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1991
- Characterization of 5‐HT3 and ‘atypical’ 5‐HT receptors mediating guinea‐pig ileal contractions in vitroBritish Journal of Pharmacology, 1990
- Mediation of 5‐hydroxytryptamine‐induced tachycardia in the pig by the putative 5‐HT4 receptorBritish Journal of Pharmacology, 1990
- A 5‐hydroxytryptamine receptor in human atriumBritish Journal of Pharmacology, 1990
- Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonistsJournal of Medicinal Chemistry, 1990
- A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930European Journal of Pharmacology, 1988
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- SOME QUANTITATIVE USES OF DRUG ANTAGONISTSBritish Journal of Pharmacology and Chemotherapy, 1959